G. Lama et al., COMBINED EFFECTS OF 13-CIS-RETINOIC ACID, TAMOXIFEN AND INTERFERON ONTHE GROWTH OF HUMAN BREAST-CANCER CELLS, Cancer letters, 100(1-2), 1996, pp. 181-189
We studied the effect of 13-cis-retinoic acid (13-cRA) alone and in co
mbination with interferons (IFNs) and tamoxifen (TAM) in two establish
ed human breast cancer cell lines: the estrogen-sensitive CG-5 and the
estrogen-insensitive MDA-MB-453 cells. 13-cRA(10(-9)-10(-5) M) signif
icantly reduced the growth of both cell lines in a dose-dependent fash
ion, after 3 and 6 days of treatment. When the retinoid (10(-9)-10(-5)
M) was combined with natural beta-IFN (100-1000 IU/ml) for 6 days, we
observed a growth inhibition more pronounced than that produced by ea
ch of the two single agents in both CG-5 and MDA-MB-453 cells, Only in
the former model was the inhibitory effect synergistic at all the dru
g concentrations used, Association of 13-cRA(10(-9)-10(-5) M) and reco
mbinant alpha 2a-IFN (100-1000 IU/ml) or TAM (10(-7)-10(-6) M) did not
determine an additive or synergistic effect on the growth of CG-5 cel
ls.